Manufactures wearable devices that deliver transcranial electromagnetic and radiofrequency treatments designed to improve brain health.
NeuroEM has raised $1.3M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
NeuroEM's investors include New York Angels, Bluelake.
NeuroEM is headquartered in Tampa, United States.
Manufactures wearable devices that deliver transcranial electromagnetic and radiofrequency treatments designed to improve brain health.
NeuroEM is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroEM — Funding & Investors." VCBacked, June 13, 2025, https://www.vcbacked.co/company/neuroem. Accessed November 13, 2026.
VCBacked. (2025). NeuroEM — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/neuroem
{{cite web |title=NeuroEM — Funding & Investors |url=https://www.vcbacked.co/company/neuroem |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at NeuroEM? Request a listing update